• control
• Biochemistry
• June 15, 2024

Assessing the potential of CRISPR-based gene editing for the treatment of beta-thalassemia – Complete Phd and Masters Thesis

[ad_1] Introduction: Beta-thalassemia is a genetic disorder characterized by the reduced production of hemoglobin, leading to severe anemia and other complications. Current treatment options, such as regular blood transfusions and iron chelation therapy, have limitations…